Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kaku, Yoichiro ^a   Imaoka, Haruki ^a   Morimatsu, Yoshitaka ^a   Komohara, Yoshihiro ^b   Ohnishi, Koji ^b   Oda, Hanako ^a   Takenaka, Shinichi ^a   Matsuoka, Masanobu ^a   Kawayama, Tomotaka ^a   Takeya, Motohiro ^b   Hoshino, Tomoaki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD204 ANTIGEN; CD206 ANTIGEN; GELATINASE B; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; MALE; SCORING SYSTEM; SMOKING;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; LECTINS, C-TYPE; LUNG; MACROPHAGES, ALVEOLAR; MALE; MANNOSE-BINDING LECTINS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CELL SURFACE; SCAVENGER RECEPTORS, CLASS A; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84900404514     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087400     Document Type: Article

References (40)

1. Peto R, Chen ZM, Boreham J (1999) Tobacco-the growing epidemic. Nat Med 5: 15-17.
2. Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620.
3. Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, et al. (2008) Interleukin-18 production and pulmonary function in COPD. Eur Respir J 31: 287-297.
4. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, et al. (1993) Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 147: 301-306. (Pubitemid 23044899)
5. Saetta M, Baraldo S, Corbino L, Turato G, Braccioni F, et al. (1999) CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 711-717. (Pubitemid 29380694)
6. Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483.
7. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. (Pubitemid 41746764)
8. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH (2006) Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol 79: 285-293. (Pubitemid 44831160)
9. Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, et al. (2008) Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol 181: 2220-2226.
10. Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, et al. (2006) IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107: 4930-4937. (Pubitemid 43882647)
11. Blumenthal RL, Campbell DE, Hwang P, DeKruyff RH, Frankel LR, et al. (2001) Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol 107: 258-264. (Pubitemid 32173902)
12. Thepen T, Van Rooijen N, Kraal G (1989) Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 170: 499-509. (Pubitemid 19204277)
13. Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM, et al. (1999) Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 66: 858-866. (Pubitemid 29532050)
14. Hogger P, Dreier J, Droste A, Buck F, Sorg C (1998) Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid- inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883-1890. (Pubitemid 28387610)
15. Schonkeren D, van der Hoorn ML, Khedoe P, Swings G, van Beelen E, et al. (2011) Differential distribution and phenotype of decidual macrophages in preeclamptic versus control pregnancies. Am J Pathol 178: 709-717.
16. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, et al. (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37: 748-755. (Pubitemid 350211645)
17. Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42: 717-727.
18. Woollard KJ, Geissmann F (2010) Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 7: 77-86.
19. Ricardo SD, van Goor H, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118: 3522-3530.
20. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease 2013. Available: www.goldcopd.com. Accessed: February, 2013.
21. The Japanese Respiratory Society Statement of theJapanese Pulmonary Function Standard. Revised edition 2001. Available: http://www.jrs.or.jp/home/ uploads/photos. Accessed: February, 2010.
22. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653. (Pubitemid 38787999)
23. Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, et al. (2007) Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 176: 49-62. (Pubitemid 47048054)
24. Komohara Y, Ohnishi K, Kuratsu J, Takeya M (2008) Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 216: 15-24.
25. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M (2009) Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int 59: 300-305.
26. Stanescu D, Sanna A, Veriter C, Kostianev S, Calcagni PG, et al. (1996) Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 51: 267-271. (Pubitemid 26086470)
27. Domagala-Kulawik J, Maskey-Warzechowska M, Kraszewska I, Chazan R (2003) The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 123: 1054-1059. (Pubitemid 36444360)
28. Goerdt S, Orfanos CE (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142. (Pubitemid 29115619)
29. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
30. Areschoug T, Gordon S (2009) Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol 11: 1160-1169.
31. Akila P, Prashant V, Suma MN, Prashant SN, Chaitra TR (2012) CD163 and its expanding functional repertoire. Clin Chim Acta 413: 669-674.
32. Martinez-Pomares L (2012) The mannose receptor. J Leukoc Biol 92: 1177-1186.
33. Ohnishi K, Komohara Y, Fujiwara Y, Takemura K, Lei X, et al. (2011) Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204). Biochem Biophys Res Commun 411: 516-522.
34. Komohara Y, Takemura K, Lei XF, Sakashita N, Harada M, et al. (2009) Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophages. Cancer Sci 100: 2160-2166.
35. Thomsen M, Nordestgaard BG, Tybjaerg-Hansen A, Dahl M (2011) Scavenger receptor AI/II truncation, lung function and COPD: a large population-based study. J Intern Med 269: 340-348.
36. Ohar JA, Hamilton RF Jr, Zheng S, Sadeghnejad A, Sterling DA, et al. (2010) COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest 137: 1098-1107.
37. Pardo A, Selman M (2006) Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 3: 383-388. (Pubitemid 43845417)
38. Sakashita N, Motooka Y, Suganuma M, Ohnishi K, Fujiwara Y, et al. (2011) A case of pulmonary capillary hemangiomatosis with pulmonary fibrosis associated with MMP-9 related pulmonary remodeling. Pathol Int 61: 306-312.
39. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 340: 1948-1953. (Pubitemid 29288270)
40. Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA, et al. (2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320: 1297-1303. (Pubitemid 30245717)